Related Experiment Video
Updated: Feb 11, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation
L Gelsomino1, S Panza1, C Giordano2
1Department of Pharmacy, Health, and Nutritional Sciences, University of Calabria, Rende, Italy.
Abstract:
The detection of recurrent mutations affecting the hormone binding domain (HBD) of estrogen receptor alpha (ERα/ESR1) in endocrine therapy-resistant and metastatic breast cancers has prompted interest in functional characterization of these genetic alterations. Here, we explored the role of HBD-ESR1 mutations in influencing the behavior of breast cancer stem cells (BCSCs), using various BC cell lines stably expressing wild-type or mutant (Y537 N, Y537S, D538G) ERα. Compared to WT-ERα clones, mutant cells showed increased CD44+/CD24- ratio, mRNA levels of stemness genes, Mammosphere Forming Efficiency (MFE), Self-Renewal and migratory capabilities. Mutant clones exhibited high expression of NOTCH receptors/ligands/target genes and blockade of NOTCH signaling reduced MFE and migratory potential. Mutant BCSC activity was dependent on ERα phosphorylation at serine 118, since its inhibition decreased MFE and NOTCH4 activation only in mutant cells. Collectively, we demonstrate that the expression of HBD-ESR1 mutations may drive BC cells to acquire stem cell traits through ER/NOTCH4 interplay. We propose the early detection of HBD-ESR1 mutations as a challenge in precision medicine strategy, suggesting the development of tailored-approaches (i.e. NOTCH inhibitors) to prevent disease development and metastatic spread in BC mutant-positive patients.
Insights
Estrogen receptor alpha (ERα) mutations in breast cancer drive stem cell traits and metastasis through ER/NOTCH4 signaling. Early detection and NOTCH inhibitors may offer new precision medicine strategies for mutant-positive patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Recurrent mutations in the estrogen receptor alpha (ERα/ESR1) hormone binding domain (HBD) are detected in endocrine therapy-resistant and metastatic breast cancers.
- Understanding the functional impact of these HBD-ESR1 mutations is crucial for developing effective treatment strategies.
Purpose of the Study:
- To investigate the role of HBD-ESR1 mutations in influencing the behavior of breast cancer stem cells (BCSCs).
- To explore the interplay between ERα mutations, stemness pathways, and NOTCH signaling in breast cancer progression.
Main Methods:
- Utilized breast cancer cell lines stably expressing wild-type (WT) or mutant (Y537N, Y537S, D538G) ERα.
- Assessed stem cell characteristics including CD44+/CD24- ratio, stemness gene expression, Mammosphere Forming Efficiency (MFE), self-renewal, and migration.
- Investigated the impact of NOTCH signaling blockade and ERα phosphorylation at serine 118.
Main Results:
- Mutant ERα clones exhibited increased stemness markers, MFE, self-renewal, and migration compared to WT-ERα clones.
- Mutant cells showed elevated NOTCH pathway activation, and NOTCH inhibition reduced MFE and migration.
- ERα phosphorylation at serine 118 was essential for MFE and NOTCH4 activation in mutant cells.
Conclusions:
- HBD-ESR1 mutations promote breast cancer stem cell traits via an ERα/NOTCH4 signaling axis.
- Early detection of HBD-ESR1 mutations is vital for precision medicine.
- Targeting NOTCH signaling may represent a therapeutic approach to prevent disease progression and metastasis in patients with ERα-mutated breast cancer.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cancers Originate from Somatic Mutations in a Single Cell
Internal Receptors
Plant Hormones
Types of Hormones
Cell Lines

